PENFINE Trademark

Trademark Overview

On Tuesday, April 12, 2022, a trademark application was filed for PENFINE with the United States Patent and Trademark Office. The USPTO has given the PENFINE trademark a serial number of 97359529. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2024. This trademark is owned by Ypsomed AG. The PENFINE trademark is filed in the Medical Instrument Products category with the following description:

Injection needles for use on humans
penfine

General Information

Serial Number97359529
Word MarkPENFINE
Filing DateTuesday, April 12, 2022
Status700 - REGISTERED
Status DateTuesday, October 1, 2024
Registration Number7523972
Registration DateTuesday, October 1, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements

Pseudo MarkPEN FINE
Goods and ServicesInjection needles for use on humans

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, April 19, 2022
Primary Code010
First Use Anywhere DateMonday, June 26, 2023
First Use In Commerce DateMonday, June 26, 2023

Trademark Owner History

Party NameHTL-STREFA S.A.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressOZORK�W 95-035
PL
Party NameYpsomed AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBurgdorf CH-3400
CH
Party NameYpsomed AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurgdorf CH-3400
CH
Party NameYpsomed AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurgdorf CH-3400
CH

Trademark Events

Event DateEvent Description
Friday, April 15, 2022NEW APPLICATION ENTERED
Tuesday, April 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 28, 2023ASSIGNED TO EXAMINER
Saturday, January 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, May 5, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, May 26, 2023ASSIGNED TO PETITION STAFF
Tuesday, May 30, 2023POST PUBLICATION AMENDMENT - ENTERED
Sunday, July 16, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, August 29, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, February 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 1, 2024SOU EXTENSION 1 FILED
Thursday, February 1, 2024SOU EXTENSION 1 GRANTED
Wednesday, May 22, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, May 22, 2024USE AMENDMENT FILED
Saturday, June 29, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, August 26, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 26, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, June 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 1, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, April 2, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 1, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

penfine humans needles injection